Inventor · disambiguated record
John Heimlich
Also filed as: HEIMLICH JOHN M · HEIMLICH JOHN MARK
3 granted patents·11 pending applications·7 citations·filing 2002–2018
59Inventor score
Top patents by PatentIndex Score
14 records- 0165US8399016B2Sustained-release tablet composition of pramipexoleAMIDON GREGORY EVERETT·Filed 2010·Granted Mar 19, 2013·5 cites·6 claims
- 0260US9668998B2Solid molecular dispersion of fesoterodine hydrogen fumarate and polymeric binderBODMEIER ROLAND·Filed 2012·Granted Jun 6, 2017·2 cites·34 claims
- 0359US2009143387A1Sustained-release tablet compositionPFIZER·Filed 2008·Application pending·0 cites
- 0451US2005042291A1Diffusion layer modulated solidsFiled 2004·Application pending·0 cites
- 0548US2005031690A1Stabilized prostaglandin formulationPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 0642US11446324B2Veterinary compositions for use in treating mastitis, and associated methodsZOETIS SERVICES LLC·Filed 2018·Granted Sep 20, 2022·0 cites·15 claims
- 0739US2005226926A1Sustained-release tablet composition of pramipexolePFIZER·Filed 2003·Application pending·0 cites
- 0839US2004228915A1Oral extended release compressed tablets of multiparticulatesFiled 2004·Application pending·0 cites
- 0938US2017281586A1Solid molecular dispersion of fesoterodine hydrogen fumarate and polymeric binderPFIZER LTD·Filed 2017·Application pending·0 cites
- 1038US2004146556A1Oral extended release tablets and methods of making and using the sameFiled 2003·Application pending·0 cites
- 1137US2003129236A1Multiple pulse extended release formulations of clindamycinFiled 2002·Application pending·0 cites
- 1235US2007196481A1Sustained-release tablet compositionAMIDON GREGORY E·Filed 2003·Application pending·0 cites
- 1334US2003133982A1Zero-order sustained release dosage forms and method of making sameFiled 2002·Application pending·0 cites
- 1433US2004137156A1Coated solid dosage form and method for preparing sameLEE ERNEST J·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →